NCT00019331
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +88 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
Clinical trial condition
Neoplasms, Ductal, Lobular, and Medullary
Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.
477 public trials
97 recruiting studies
Neoplasms, Ductal, Lobular, and Medullary trial results
NCT00245024
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
NCT00304096
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
- Locations
-
- University of Virginia Cancer Center Charlottesville, Virginia, United States
NCT00244959
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00215605
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +23 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT00004604
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +92 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT01107080
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Completed
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
- Conditions
- Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States